Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Anticoagulants market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Anticoagulants market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Anticoagulants market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Anticoagulants products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Anticoagulants products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Anticoagulants market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Anticoagulants development has been the leading industry trend of Anticoagulants market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Anticoagulants Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Platelet aggregation inhibitors (PAI),Low-molecular-weight Heparin (LMWH),Direct thrombin inhibitor (DTI),Direct factor Xa inhibitors (DFXa),Vitamin K antagonists (VKA),Others |
| By Application Outlook |
VTE,ACS/MI,AF,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Sanofi,Bayer,Boehringer Ingelheim,Johnson & Johnson,Genentech (Roche),AstraZeneca,Bristol-Myers Squibb,Aspen,Lilly,Otsuka,Pfizer,Daiichi Sankyo,The Medicines Company |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Sanofi
- Bayer
- Boehringer Ingelheim
- Johnson & Johnson
- Genentech (Roche)
- AstraZeneca
- Bristol-Myers Squibb
- Aspen
- Lilly
- Otsuka
- Pfizer
- Daiichi Sankyo
- The Medicines Company
Anticoagulants Market, By Type
- Platelet aggregation inhibitors (PAI)
- Low-molecular-weight Heparin (LMWH)
- Direct thrombin inhibitor (DTI)
- Direct factor Xa inhibitors (DFXa)
- Vitamin K antagonists (VKA)
- Others
Anticoagulants Market, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Anticoagulants Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Anticoagulants Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Anticoagulants Industry Overview
2.1 Global Anticoagulants Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Anticoagulants Global Import Market Analysis
2.1.2 Anticoagulants Global Export Market Analysis
2.1.3 Anticoagulants Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Platelet aggregation inhibitors (PAI)
2.2.2 Low-molecular-weight Heparin (LMWH)
2.2.3 Direct thrombin inhibitor (DTI)
2.2.4 Direct factor Xa inhibitors (DFXa)
2.2.5 Vitamin K antagonists (VKA)
2.2.6 Others
2.3.2 ACS/MI
2.3.3 AF
2.3.4 Other
2.4.2 Global Anticoagulants Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Anticoagulants Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Anticoagulants Manufacturer Market Share
2.4.5 Top 10 Anticoagulants Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Anticoagulants Market
2.4.7 Key Manufacturers Anticoagulants Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Anticoagulants Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Anticoagulants Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Anticoagulants Market Size Categorized by Regions
4.1 Global Anticoagulants Revenue, Sales and Market Share by Regions
4.1.1 Global Anticoagulants Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anticoagulants Revenue and Market Share by Regions (2015-2020)
4.2 Europe Anticoagulants Sales and Growth Rate (2015-2020)
4.3 APAC Anticoagulants Sales and Growth Rate (2015-2020)
4.4 North America Anticoagulants Sales and Growth Rate (2015-2020)
4.5 South America Anticoagulants Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Anticoagulants Sales and Growth Rate (2015-2020)
5 Europe Anticoagulants Market Size Categorized by Countries
5.1 Europe Anticoagulants Sales, Revenue and Market Share by Countries
5.1.1 Europe Anticoagulants Sales by Countries (2015-2020)
5.1.2 Europe Anticoagulants Revenue by Countries (2015-2020)
5.1.3 Germany Anticoagulants Sales and Growth Rate (2015-2020)
5.1.4 UK Anticoagulants Sales and Growth Rate (2015-2020)
5.1.5 France Anticoagulants Sales and Growth Rate (2015-2020)
5.1.6 Russia Anticoagulants Sales and Growth Rate (2015-2020)
5.1.7 Italy Anticoagulants Sales and Growth Rate (2015-2020)
5.1.8 Spain Anticoagulants Sales and Growth Rate (2015-2020)
5.2 Europe Anticoagulants Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Anticoagulants Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Anticoagulants Sales Market Share by Type (2015-2020)
5.3.2 Europe Anticoagulants Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Anticoagulants Sales Market Share by Application (2015-2020)
6 Asia-Pacific Anticoagulants Market Size Categorized by Countries
6.1 Asia-Pacific Anticoagulants Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Anticoagulants Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Anticoagulants Revenue by Countries (2015-2020)
6.1.3 China Anticoagulants Sales and Growth Rate (2015-2020)
6.1.4 Japan Anticoagulants Sales and Growth Rate (2015-2020)
6.1.5 Korea Anticoagulants Sales and Growth Rate (2015-2020)
6.1.6 India Anticoagulants Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Anticoagulants Sales and Growth Rate (2015-2020)
6.1.8 Australia Anticoagulants Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Anticoagulants Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Anticoagulants Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Anticoagulants Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Anticoagulants Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Anticoagulants Sales and Market Share by Application (2015-2020)
7 North America Anticoagulants Market Size Categorized by Countries
7.1 North America Anticoagulants Sales, Revenue and Market Share by Countries
7.1.1 North America Anticoagulants Sales by Countries (2015-2020)
7.1.2 North America Anticoagulants Revenue by Countries (2015-2020)
7.1.3 United States Anticoagulants Sales and Growth Rate (2015-2020)
7.1.4 Canada Anticoagulants Sales and Growth Rate (2015-2020)
7.1.5 Mexico Anticoagulants Sales and Growth Rate (2015-2020)
7.2 North America Anticoagulants Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Anticoagulants Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Anticoagulants Sales Market Share by Type (2015-2020)
7.3.2 North America Anticoagulants Revenue and Revenue Share by Type (2015-2020)
7.4 North America Anticoagulants Sales Market Share by Application (2015-2020)
8 South America Anticoagulants Market Size Categorized by Countries
8.1 South America Anticoagulants Sales, Revenue and Market Share by Countries
8.1.1 South America Anticoagulants Sales by Countries (2015-2020)
8.1.2 South America Anticoagulants Revenue by Countries (2015-2020)
8.1.3 Brazil Anticoagulants Sales and Growth Rate (2015-2020)
8.2 South America Anticoagulants Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Anticoagulants Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Anticoagulants Sales Market Share by Type (2015-2020)
8.3.2 South America Anticoagulants Revenue and Revenue Share by Type (2015-2020)
8.4 South America Anticoagulants Sales Market Share by Application (2015-2020)
9 Middle East and Africa Anticoagulants Market Size Categorized by Countries
9.1 Middle East and Africa Anticoagulants Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anticoagulants Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Anticoagulants Revenue by Countries (2015-2020)
9.1.3 GCC Countries Anticoagulants Sales and Growth Rate (2015-2020)
9.1.4 Turkey Anticoagulants Sales and Growth Rate (2015-2020)
9.1.5 Egypt Anticoagulants Sales and Growth Rate (2015-2020)
9.1.6 South Africa Anticoagulants Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Anticoagulants Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Anticoagulants Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Anticoagulants Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Anticoagulants Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Anticoagulants Sales Market Share by Application (2015-2020)
10 Global Anticoagulants Market Segment by Type
10.1 Global Anticoagulants Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Anticoagulants Sales and Market Share by Type (2015-2020)
10.1.2 Global Anticoagulants Revenue and Market Share by Type (2015-2020)
10.2 Platelet aggregation inhibitors (PAI) Sales Growth Rate and Price
10.2.1 Global Platelet aggregation inhibitors (PAI) Sales Growth Rate (2015-2020)
10.2.2 Global Platelet aggregation inhibitors (PAI) Price (2015-2020)
10.3 Low-molecular-weight Heparin (LMWH) Sales Growth Rate and Price
10.3.1 Global Low-molecular-weight Heparin (LMWH) Sales Growth Rate (2015-2020)
10.3.2 Global Low-molecular-weight Heparin (LMWH) Price (2015-2020)
10.4 Direct thrombin inhibitor (DTI) Sales Growth Rate and Price
10.4.1 Global Direct thrombin inhibitor (DTI) Sales Growth Rate (2015-2020)
10.4.2 Global Direct thrombin inhibitor (DTI) Price (2015-2020)
10.5 Direct factor Xa inhibitors (DFXa) Sales Growth Rate and Price
10.5.1 Global Direct factor Xa inhibitors (DFXa) Sales Growth Rate (2015-2020)
10.5.2 Global Direct factor Xa inhibitors (DFXa) Price (2015-2020)
10.6 Vitamin K antagonists (VKA) Sales Growth Rate and Price
10.6.1 Global Vitamin K antagonists (VKA) Sales Growth Rate (2015-2020)
10.6.2 Global Vitamin K antagonists (VKA) Price (2015-2020)
10.7 Others Sales Growth Rate and Price
10.7.1 Global Others Sales Growth Rate (2015-2020)
10.7.2 Global Others Price (2015-2020)
11.1 Global AnticoagulantsSales Market Share by Application (2015-2020)
11.2 VTE Sales Growth Rate (2015-2020)
11.3 ACS/MI Sales Growth Rate (2015-2020)
11.4 AF Sales Growth Rate (2015-2020)
11.5 Other Sales Growth Rate (2015-2020)
12.1 Global Anticoagulants Revenue, Sales and Growth Rate (2020-2027)
12.2 Anticoagulants Market Forecast by Regions (2020-2027)
12.2.1 Europe Anticoagulants Market Forecast (2020-2027)
12.2.2 APAC Anticoagulants Market Forecast (2020-2027)
12.2.3 North America Anticoagulants Market Forecast (2020-2027)
12.2.4 South America Anticoagulants Market Forecast (2020-2027)
12.2.5 Middle East & Africa Anticoagulants Market Forecast (2020-2027)
12.3 Anticoagulants Market Forecast by Type (2020-2027)
12.3.1 Global Anticoagulants Sales Forecast by Type (2020-2027)
12.3.2 Global Anticoagulants Market Share Forecast by Type (2020-2027)
12.4 Anticoagulants Market Forecast by Application (2020-2027)
12.4.1 Global Anticoagulants Sales Forecast by Application (2020-2027)
12.4.2 Global Anticoagulants Market Share Forecast by Application (2020-2027)
13 Analysis of Anticoagulants Industry Key Manufacturers
13.1 Sanofi
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Sanofi Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Sanofi News
13.2 Bayer
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Bayer Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Bayer News
13.3 Boehringer Ingelheim
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Boehringer Ingelheim Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Boehringer Ingelheim News
13.4 Johnson & Johnson
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Johnson & Johnson Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Johnson & Johnson News
13.5 Genentech (Roche)
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Genentech (Roche) Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Genentech (Roche) News
13.6 AstraZeneca
13.6.1 Company Details
13.6.2 Product Information
13.6.3 AstraZeneca Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 AstraZeneca News
13.7 Bristol-Myers Squibb
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Bristol-Myers Squibb Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Bristol-Myers Squibb News
13.8 Aspen
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Aspen Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Aspen News
13.9 Lilly
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Lilly Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Lilly News
13.10 Otsuka
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Otsuka Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Otsuka News
13.11 Pfizer
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Pfizer Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Pfizer News
13.12 Daiichi Sankyo
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Daiichi Sankyo Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 Daiichi Sankyo News
13.13 The Medicines Company
13.13.1 Company Details
13.13.2 Product Information
13.13.3 The Medicines Company Anticoagulants Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 The Medicines Company News
15 Appendix
